25.01.2024 • NewsSolvayHydrogen Peroxidesphotovoltaic

Solvay and Huatai Expand Hydrogen Peroxide Capacity in China

In a move to meet the rising demand from the photovoltaic industry, Solvay is expanding the is hydrogen peroxide capacity of its Shandong Huatai Interox Chemical site in China, a joint venture (JV) with Huatai Chemical.

The investment will enable the site, which is situated in the Dongying Technical and Economics Development Zone of the Shandong Province, to produce 48 kt of photovoltaic-grade hydrogen peroxide annually by 2025.

"In alignment with China’s ambitious carbon neutrality targets, our collaboration positions Solvay as a key contributor. Leveraging cutting-edge technologies and building on our established presence in the high-purity hydrogen peroxide market, this strategic partnership capitalizes on the rapid expansion of China’s photovoltaic market,” said Philippe Kehren, Solvay’s CEO.

"Our joint venture with Solvay is a testament to our commitment to innovation and sustainability. This expansion is not just about increasing capacity; it's about contributing significantly to China's carbon neutrality goals and the photovoltaic industry's growth. By boosting our site's capability, we are not only meeting the demands of a rapidly evolving market but also reinforcing our position as a key player in the renewable energy sector," added Wang Yukang, chairman of Huatai Chemicals.

© Diyana Dimitrova/Shutterstock
© Diyana Dimitrova/Shutterstock

Company

Logo:

Solvay

Rue du Prince Albert 33
1050 Bruxelles
Belgium

Company contact







CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.